We are happy to summarize the third international symposium for researchers and clinicians on Wiskott Aldrich Syndrome which took place in Munich Germany. During the event we were discussing the latest research and analysis related to this rare disease.
36 participants from 14 countries were discussing innovative perspectives in both basic and clinical research. The scientific programme which was followed successfully includes advances in clinical practice, novel therapeutic approaches and new insights into stem-cell and cellular therapies. we had a great Gene Therapy expert panel discussing the future of this technology and how can the participants help overcoming the current drawback in the commercial plans for making this technology available for WAS patients.
You can find a short event summary with 2 page summary of each presentation on our Event summary page.
- Expanding WAS/XLT and WASp research.
- Bridging the gap between basic and clinical research to speed up applications
- Foster collaboration among researchers.
- Attract young researchers to focus on WAS/XLT and WASp
Prof. Adrian Thrasher - Institute of child health, London.
Prof. Anna Villa - Telethon Institute for Gene Therapy (SR-Tiget).
Prof. Michael Albert - Dr. von Hauner Children’s Hospital, LMU Munich.
Prof. Bobby Gaspar - Institute of child health, London.
Dr. Sumathi Iyengar - The Wiskott Aldrich Foundation.
Mr. Amir Kedar - The Wiskott Aldrich Syndrome association (R.A.).